Our detection of TDP-43-dependent cryptic peptides in CSF and blood of presymptomatic C9orf72 mutation carriers also aligns with a common theme of neurodegenerative diseases—that pathogenic mechanisms often begin years before the emergence of clinically relevant symptoms. Here, TARDBP is linked to neurodegenerative disease.